Thermo Fisher Scientific Inc.
TMO
$466.60
$0.0250.01%
NYSE
| 06/28/2025 | 03/29/2025 | 12/31/2024 | 09/28/2024 | 06/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.62B | 1.51B | 1.83B | 1.63B | 1.55B |
| Total Depreciation and Amortization | 676.00M | 705.00M | 747.00M | 734.00M | 791.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -168.00M | -64.00M | 119.00M | -228.00M | -162.00M |
| Change in Net Operating Assets | -726.00M | -1.43B | 594.00M | 30.00M | -216.00M |
| Cash from Operations | 1.40B | 723.00M | 3.29B | 2.17B | 1.96B |
| Capital Expenditure | -294.00M | -362.00M | -480.00M | -272.00M | -301.00M |
| Sale of Property, Plant, and Equipment | 1.00M | 12.00M | 17.00M | 20.00M | 16.00M |
| Cash Acquisitions | -- | -- | 0.00 | -3.13B | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.00M | -177.00M | 483.00M | -194.00M | 32.00M |
| Cash from Investing | -288.00M | -527.00M | 20.00M | -3.58B | -253.00M |
| Total Debt Issued | 0.00 | 2.84B | 0.00 | 0.00 | -1.00M |
| Total Debt Repaid | -787.00M | -838.00M | -2.50B | -1.11B | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00 | -2.00B | -1.00B | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -162.00M | -149.00M | -149.00M | -150.00M | -149.00M |
| Other Financing Activities | -42.00M | 45.00M | -17.00M | 67.00M | 35.00M |
| Cash from Financing | -991.00M | -102.00M | -3.67B | -1.19B | -115.00M |
| Foreign Exchange rate Adjustments | 311.00M | 37.00M | -273.00M | 175.00M | -15.00M |
| Miscellaneous Cash Flow Adjustments | 0.00 | 1.00M | -1.00M | 0.00 | 1.00M |
| Net Change in Cash | 431.00M | 132.00M | -630.00M | -2.43B | 1.58B |